News

intrasaccular flow disruptor coronary aneurysm

A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.

The high-risk patients who require urgent or emergent TAVR are often excluded from major clinical trials. To learn more about this population, researchers explored data from nearly 600 patients treated at high-volume facilities. 

Xiaodong Zhang, MD, PhD,

The first FDA-approved pacing lead specifically developed for LBBAP is now being implanted throughout the United States. 

Guerbet

Regulators recently scolded the France-based pharmaceutical firm for safety issues that occurred at its plant in Raleigh, North Carolina, which produces imaging contrast agents. 

Wisconsin Governor Tony Evers Gail's Law

Dubbed "Gail's Law" after a breast cancer care advocate, the passage follows years of advocacy from radiologists and patients. 

handcuffs arrested arrest jail

Sophia Shaklian, 38, of Los Angeles, and accomplices bilked Medicare of millions by submitting false claims for diagnostic imaging and hospice care that was unnecessary or never administered. 

MARS Bioimaging extremity scanner

The system is designed for point-of-care settings such as outpatient offices, sports medicine practices and urgent care clinics.

patient experience

Meanwhile members of Gen Z are twice as likely as other generations to get sneaky about their use of medical AI. 

The HEARTS Act is focused on improving cardiomyopathy education and awareness while getting more AEDs in schools. The ACC, AHA and other medical societies have supported the bipartisan bill, which now heads to the president's desk to be signed into law.

FDA Commissioner Robert Califf, MD, a cardiologist, speaking at the TCT interventional cardiology conference on health disparities in the U.S. health system and paying more for care has not resulted in better outcomes. #healthdisparities #healthequity

FDA Commissioner Robert Califf, MD, talked to Cardiovascular Business about healthcare spending, inconsistent patient outcomes and much more.

Johnson & Johnson MedTech partnered with the Advanced Cardiac Therapies Improving Outcomes Network to confirm these devices could safely and effectively treat younger patients. 

Thumbnail

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Around the web

A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.